D'ANTONIO, LUIGI
 Distribuzione geografica
Continente #
EU - Europa 142
NA - Nord America 106
AS - Asia 57
SA - Sud America 17
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 325
Nazione #
US - Stati Uniti d'America 104
IT - Italia 73
SG - Singapore 37
IE - Irlanda 24
SE - Svezia 18
BR - Brasile 16
IN - India 14
RU - Federazione Russa 7
DE - Germania 5
GB - Regno Unito 4
FI - Finlandia 3
NL - Olanda 3
CA - Canada 2
EG - Egitto 2
FR - Francia 2
AT - Austria 1
BD - Bangladesh 1
BY - Bielorussia 1
EC - Ecuador 1
EU - Europa 1
IQ - Iraq 1
JP - Giappone 1
LB - Libano 1
MO - Macao, regione amministrativa speciale della Cina 1
PK - Pakistan 1
UA - Ucraina 1
Totale 325
Città #
Dublin 24
Chandler 23
Pescara 22
Singapore 22
The Dalles 16
Chennai 11
Camerino 8
Princeton 8
Chieti 7
Romola 6
Santa Clara 5
Altamura 4
Frankfurt am Main 4
Wilmington 4
Helsinki 3
Lanciano 3
Terni 3
Ashburn 2
Los Angeles 2
Manchester 2
Montesilvano Marina 2
Perugia 2
Pune 2
Silver Spring 2
Toronto 2
Andover 1
Aracaju 1
Araxá 1
Baghdad 1
Betim 1
Bexley 1
Boston 1
Charleston 1
Chicago 1
Coimbatore 1
Cranston 1
Curitiba 1
Dhaka 1
Garça 1
Juiz de Fora 1
Kopeysk 1
Macao 1
Manta 1
Milan 1
Mogi das Cruzes 1
Moscow 1
Mossoró 1
New York 1
Orlando 1
Oxford 1
Penápolis 1
Peruíbe 1
Pontal do Paraná 1
Rio de Janeiro 1
Rostov-on-Don 1
Sacramento 1
Salisbury 1
San Giorgio Del Sannio 1
San Giovanni Teatino 1
Seattle 1
Senador Firmino 1
São Gonçalo 1
São Paulo 1
Teófilo Otoni 1
Totale 228
Nome #
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival 70
Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival 66
Hindering triple negative breast cancer progression by targeting endogenous interleukin‐30 requires IFNγ signaling 53
Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome 53
null 39
null 36
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality 17
The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs 16
Totale 350
Categoria #
all - tutte 2.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 3 0 2 0 0 0
2021/202229 1 0 4 4 3 5 2 1 1 2 2 4
2022/2023105 5 14 3 9 7 16 2 7 13 22 7 0
2023/202454 4 5 2 0 0 16 9 9 0 1 0 8
2024/2025157 5 12 14 6 9 7 24 16 14 10 23 17
Totale 350